Definium Therapeutics

DFTX

Datum	Typ	Insider	Position	Ø-Preis	Volumen
25.9.2026	Verkauf	Roberts, Brandi	Chief Financial Officer	36,6 $	123.497 $
25.9.2026	Verkauf	Sullivan, Mark	Chief Legal Officer	36,6 $	513.845 $
25.9.2026	Verkauf	Wiley, Matthew T.	Chief Commercial Officer	36,6 $	113.257 $
25.9.2026	Verkauf	Barrow, Robert	Chief Executive Officer	36,6 $	1.153.784 $
25.9.2026	Verkauf	Karlin, Daniel	Chief Medical Officer	36,6 $	396.894 $
3.9.2026	Verkauf	Barrow, Robert	Chief Executive Officer	37,9 $	721.733 $
25.6.2026	Verkauf	Wiley, Matthew T.	Chief Commercial Officer	45,0 $	129.101 $
25.6.2026	Verkauf	Barrow, Robert	Chief Executive Officer	45,0 $	1.315.236 $
25.6.2026	Verkauf	Roberts, Brandi	Chief Financial Officer	45,0 $	135.675 $
25.6.2026	Verkauf	Karlin, Daniel	Chief Medical Officer	45,0 $	451.876 $
25.6.2026	Verkauf	Sullivan, Mark	Chief Legal Officer	45,0 $	585.750 $
25.3.2026	Verkauf	Barrow, Robert	Chief Executive Officer	18,5 $	451.241 $
25.3.2026	Verkauf	Sullivan, Mark	Chief Legal Officer	18,5 $	197.666 $
25.3.2026	Verkauf	Karlin, Daniel	Chief Medical Officer	18,5 $	148.092 $